Literature DB >> 17534771

[CT-guided interventions in children].

D Honnef1, J E Wildberger, H Schubert, C Hohl, R W Günther, A Mahnken.   

Abstract

In pediatric CT-guided interventions specific features have to be taken into account. Due to a lack of cooperation or limited ability to cooperate, procedures are often performed using analgosedation or general anesthesia. To provide radiation protection, justified indication for CT-guided intervention is necessary and sonography and MRI are to be preferred whenever possible. CT examinations also need to be dose-adapted with sequential scanning and a tube voltage and tube current reduction compared to pediatric diagnostic CT studies must be ensured. Gonad shields are recommended for male patients. Biopsy device selection depends on the assumed tumor entity since histology and also immunohistochemical, molecular pathological and cytogenetical analysis are necessary to differentiate pediatric tumors (small, round, blue cell tumors). In addition to diagnostic procedures, therapeutic interventions (drainage, injection therapies, neurolysis, and radiofrequency ablation) can also be used in children and can provide an alternative to surgery in selected cases. With justified indications and precise performance, CT-guided interventions can be successful in pediatric patients with limited risks.

Entities:  

Mesh:

Year:  2007        PMID: 17534771     DOI: 10.1055/s-2007-963162

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  Computed tomography-guided biopsies in children: accuracy, efficiency and dose usage.

Authors:  Tatjana Gruber-Rouh; Axel Thalhammer; Thomas Klingebiel; Nour-Eldin A Nour-Eldin; Thomas J Vogl; Katrin Eichler; Nagy Naguib; Martin Beeres
Journal:  Ital J Pediatr       Date:  2017-01-06       Impact factor: 2.638

2.  Robotic Assistance System for Cone-Beam Computed Tomography-Guided Percutaneous Needle Placement.

Authors:  Michael Kostrzewa; Andreas Rothfuss; Torben Pätz; Markus Kühne; Stefan O Schoenberg; Steffen J Diehl; Jan Stallkamp; Nils Rathmann
Journal:  Cardiovasc Intervent Radiol       Date:  2021-08-19       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.